You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 2, February 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Genetic Disorders
 •Men's Health
 •Men's Health, Other
 •Neurogenetics
 •Neurology, Other
 •Alert me on articles by topic

X-linked Hyper-IgM Syndrome Associated With a Rapid Course of Multifocal Leukoencephalopathy

Zsuzsanna Aschermann, MD; Eva Gomori, MD, PhD; Gabor G. Kovacs, MD, PhD; Endre Pal, MD, PhD; Gabor Simon, MD, PhD; Samuel Komoly, MD, DSc; Laszlo Marodi, MD, DSc; Zsolt Illes, MD, PhD

Arch Neurol. 2007;64(2):273-276.

Objective  To report an exceptional association between X-linked hyper-IgM syndrome and progressive multifocal leukoencephalopathy.

Design  Clinical, immunological, and histological analysis.

Patient  A 19-year-old male patient with X-linked hyper-IgM syndrome developed typical signs and symptoms of progressive multifocal leukoencephalopathy.

Results  The serum level of IgA was decreased; the serum level of IgM was slightly increased; and the serum level of IgG was normal as a result of monthly infusions of immunoglobulin. The expression of CD40 ligand on T cells was markedly reduced in the patient. Magnetic resonance imaging indicated confluent lesions involving the majority of the right hemisphere with a mass effect. The patient died after 6 weeks despite combined antiviral treatment.

Conclusion  Progressive multifocal leukoencephalopathy may follow a rapid course in patients with X-linked hyper-IgM syndrome because of global defects of cellular and B cell responses.


Author Affiliations: Departments of Neurology (Drs Aschermann, Pal, Komoly, and Illes) and Pathology (Dr Gomori), University of Pecs, Pecs, Hungary; Department of Neuropathology, National Institute of Neurology and Psychiatry, Budapest, Hungary (Dr Kovacs); Department of Pediatrics, Szent Gyorgy County Hospital, Szekesfehervar, Hungary (Dr Simon); and Department of Infectious and Pediatric Immunology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary (Dr Marodi).







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.